Home › Drug Use and Addiction › NCT06559774
The Hastiin Bidziil (Strong Man) Intervention
The Hastiin Bidziil (Strong Man) Intervention: A Study to Measure the Effectiveness of a Secondary Prevention Program Aimed at Reducing Substance Use Among Adult Native Men
Who can join
Ages 18 and older · Men
Full eligibility criteria
Inclusion Criteria: * Self-identify as American Indian * Self-identify as a man * Age 18 years or older at time of enrollment * Screen positive for lifetime use of alcohol and/or drugs, except for tobacco use only * Reside within \~60 miles of a study community (Fort Defiance, AZ; Chinle, AZ) Exclusion Criteria: * Any condition that would affect successful participation (e.g., planned move) * Profound disability that limits the ability to participate in assessments or interventions * Participated in the preliminary phase of this study to adapt CETA for this project
About the study
The Hastiin Bidziil (Strong man) Intervention study is part of a larger project called, Community-Driven Indigenous Research, Cultural Strengths \& Leadership to Advance Equity in Substance Use Outcomes (CIRCLE) Center of Excellence. CIRCLE aims to address drug use related health problems in collaboration with diverse Indigenous communities. This study is a randomized controlled trial study to measure the effectiveness of a secondary prevention program, called Hastiin Bidziil (Strong Man), aimed at reducing substance use among Native American Indian (AI) men ages 18 years and older
What is being tested
- Hastiin Bidziil (behavioral)
- Control condition - vehicle maintenance (other)
Sponsor: Johns Hopkins Bloomberg School of Public Health · Participants: 160 · Started: Jun 18, 2025
Contact the study team
- Kyann Dedman-Cisco, MPH · Phone: 928-674-6824
- Marissa Begay, MA · Phone: 928-674-6824
Official record on ClinicalTrials.gov — NCT06559774
Locations in the U.S.
| Arizona | Navajo Nation Center for Indigenous Health - Chinle, Chinle Navajo Nation Center for Indigenous Health - Fort Defiance, Fort Defiance |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.